Drug recall · March 7, 2018
Acyclovir Tablets recall
Why: Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets in some of the blister cavities.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Acyclovir Tablets, USP, 400 mg, 50 Tablets (5 x 10) unit dose blisters [NDC 50268-061-11] per carton [NDC 50268-061-15], Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478
- Lots / codes
Lot: 19900, exp 05/2019
- Quantity
- 630 cartons
- Company
- Apace KY LLC, Fountain Run, KY
- Distribution
- Nationwide
- Initiated
- February 9, 2018 · Voluntary: Firm initiated
- Classified
- February 23, 2018
- Reported
- March 7, 2018
- Ended
- September 10, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Acyclovir
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.